Everything you need to win Catherine Owen Adams — in one platform.
Who to reach, what to say, and why now on Catherine Owen Adams — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Catherine Owen Adams — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
Catherine Owen Adams Succeeds Steve Davis As CEO At Acadia Pharmaceuticals Inc.
PUBLIC · ACADSep 23, 2024•over 1 year ago
Position
Chief Executive Officer
Company
Acadia Pharmaceuticals
Catherine Owen Adams
San Diego
Description
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) has announced the appointment of Catherine Owen Adams as the new Chief Executive Officer (CEO), succeeding Steve Davis. Catherine Owen Adams brings extensive pharmaceutical industry experience to her new role, with proven leadership in driving growth and innovation.
Company Information
Company
Acadia Pharmaceuticals
Location
San Diego, California, United States
About
Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis and the first and only FDA-approved drug for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Prader-Willi syndrome, Alzheimer’s disease psychosis and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders.
San Diego